Updates are available Correction dated 2023-08-24
Click to view Correction: https://doi.org/10.1007/s00134-023-07197-3
-
Authors
Giamarellos-Bourboulis, Evangelos J. http://orcid.org/0000-0003-4713-3911
,
Zinkernagel, Annelies S.
,
De Robertis, Edoardo
,
Azoulay, Élie
,
De Luca, Daniele
,
Artigas, Antonio
Schlapbach, Luregn J
Daniels, Ron
Reinhart, Konrad
Reinhart, Konrad
Baño, Jesús Rodríguez
Zacharowski, Kai
Cecconi, Maurizio
- License Information
-
More Information
Article History
Received: 16 April 2023
Accepted: 1 June 2023
First Online: 1 August 2023
Change Date: 24 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-023-07197-3
Declarations
:
: The authors do not have conflict of interest related to this manuscript. AA is Consultant and Scientific Advisor of Grifols, Lilly Foundation, Apeptico, Aerogen, Fabentech; invited speaker of Grifols, Aerogen, Abionic; receiver of restricted research grant from Grifols, Apeptico, Abionic, Loop Diagnostic. EDR receives honoraria from Baxter, Fresenius, Aspen, Fisher. EJG-B has received honoraria from Abbott CH, bioMérieux, Brahms GmbH, Fabentech, GSK, InflaRx GmbH, Sobi and XBiotech Inc; independent educational grants from Abbott CH, AxisShield, bioMérieux Inc, InflaRx GmbH, Johnson & Johnson, MSD, Novartis, Sobi and XBiotech Inc.; and funding from the Horizon2020 Marie Skłodowska-Curie International Training Network “the European Sepsis Academy” (granted to the National and Kapodistrian University of Athens), and the Horizon 2020 European Grants ImmunoSep and RISCinCOVID (granted to the Hellenic Institute for the Study of Sepsis) and the Horizon Health grant EPIC-CROWN-2 (granted to the Hellenic Institute for the Study of Sepsis). EA provides lectures for Alexion Sanofi Pfizer and Mindray.
